A graft-versus-colonic cancer effect of allogeneic stem cell transplantation

Bone Marrow Transplant. 2001 Dec;28(12):1161-6. doi: 10.1038/sj.bmt.1703287.

Abstract

Allogeneic stem cell transplantation (ASCT) has proved to have an important immune-mediated anti-tumour effect in patients with haematologic malignancies. There is also evidence of such an effect in patients with malignant tumours. We studied this effect of ASCT in a patient with colorectal cancer. A 77-year-old man having a primarily resected colonic cancer with disseminated lymph node involvement received ASCT from his HLA-identical sibling as the only treatment. Mixed haematopoietic chimerism was monitored using PCR-amplification of variable number tandem repeats and tumour size, assessed by repeated CT scans. Recipient leucocytes were gradually replaced by donor cells for 1 month. Continuous resolution of lymph node metastases was seen together with clinical graft-versus-host disease (GVHD). The patient died of pneumonia and cardiac insufficiency 4 months after transplantation. At autopsy, most of the metastases were necrotic, with few remaining tumour cells. Clinical and histopathological postmortem results showed a graft-versus-colorectal cancer effect.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Chimera
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / therapy*
  • Graft vs Tumor Effect*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Male
  • Tomography, X-Ray Computed
  • Transplantation, Homologous